NVTA Market Cap History
Below is a table of the NVTA market cap history going back to 2/28/2015:

Date NVTA Market Cap
2/28/2015594.27M
4/30/2015348.42M
7/31/2015317.82M
10/30/2015243.28M
3/2/2016288.11M
4/30/2016305.79M
7/29/2016282.97M
10/28/2016238.48M
2/28/2017435.58M
4/28/2017466.73M
7/28/2017414.11M
10/27/2017456.49M
3/2/2018367.35M
4/27/2018376.35M
8/3/2018570.34M
11/2/20181.09B
2/22/20191.48B
4/26/20192.14B
7/26/20192.44B
11/1/20191.61B
2/24/20202.19B
5/1/20201.93B
7/31/20203.85B
10/30/20206.93B
2/19/20219.92B
4/30/20216.97B
7/30/20216.08B
10/29/20216.00B
2/25/20222.42B
4/29/20221.22B

Also see: NVTA Shares Outstanding History
and NVTA YTD Return
NVTA Historical Market Cap:
+10.53% CAGR
NVTA Historical Market Cap: +10.53% CAGR

Mouse over chart for data details
2/28/2015 ...4/29/2022
Invitae is in the business of delivering genetic testing services that support a lifetime of patient care from inherited disease diagnoses, to family planning, to proactive health screening to personalized diagnosis, treatment and monitoring of cancer. Those tests are delivered via a platform that serves patients, healthcare providers, biopharma companies and other partners, thereby capturing the potential of genetics and helping to expand its use across the healthcare continuum. Co. applies proprietary design, process automation, robotics and bioinformatics software solutions to achieve efficiencies in sample processing and variant interpretation, allowing medical interpretation at scale. We show 30 historical shares outstanding datapoints in our NVTA shares outstanding history coverage, used to compute NVTA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing NVTA market cap history over the course of time is important for investors interested in comparing NVTA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of NVTA versus a peer is one thing; comparing NVTA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like NVTA can fluctuate over the course of history. With this page we aim to empower investors researching NVTA by allowing them to research the NVTA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree NVTA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Invitae (NVTA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

NVTR Market Cap History
NVUS Market Cap History
NXTC Market Cap History
NXTM Market Cap History
NYMX Market Cap History
OBLN Market Cap History
OCGN Market Cap History
OCUL Market Cap History
OCUP Market Cap History
OCX Market Cap History
More Healthcare companies »

 

NVTA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.